Julia Abernethy
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
- HIV/AIDS drug development and treatment 2
- HIV/AIDS Research and Interventions 2
-
- Urinary Tract Infections Management 2
- HIV, Drug Use, Sexual Risk 1
- Co-authors
- Alan P. Johnson (3 shared papers)Elizabeth Sheridan (2 shared papers)Rebecca Guy (2 shared papers)Russell Hope (3 shared papers)John Davies (1 shared paper)G. Duckworth (1 shared paper)A. Pearson (1 shared paper)N A Hinton (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (2 papers)Epidemiology and Infection (1 paper)Clinical Microbiology and Infection (1 paper)Journal of Medical Microbiology (1 paper)Antiviral Therapy (1 paper)
- Partner nations
- United KingdomMalawiNetherlands
In The Last Decade
Julia Abernethy
7 papers receiving 306 citations
Peers
Comparison fields: 5 of 51
- Applied Microbiology and Biotechnology 57
- Molecular Medicine 102
- Clinical Biochemistry 77
- Virology 46
- Endocrinology 47
Countries citing papers authored by Julia Abernethy
This map shows the geographic impact of Julia Abernethy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Abernethy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Abernethy more than expected).
Fields of papers citing papers by Julia Abernethy
This network shows the impact of papers produced by Julia Abernethy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Abernethy. The network helps show where Julia Abernethy may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Abernethy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 100 | |
| 2 | 2015 | 72 | |
| 3 | Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia. | 2007 | 48 |
| 4 | 2007 | 44 | |
| 5 | 2016 | 36 | |
| 6 | 2009 | 6 | |
| 7 | 2017 | 2 |
About Julia Abernethy
Julia Abernethy is a scholar working on Infectious Diseases, Epidemiology, Virology, Molecular Medicine and Endocrinology, having authored 7 papers that have together received 308 indexed citations. Recurring topics across this work include HIV Research and Treatment (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Escherichia coli research studies (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV/AIDS Research and Interventions (2 papers), Antibiotic Resistance in Bacteria (2 papers), Urinary Tract Infections Management (2 papers) and HIV, Drug Use, Sexual Risk (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (57 citations), Molecular Medicine (102 citations), Clinical Biochemistry (77 citations), Virology (46 citations) and Endocrinology (47 citations). Julia Abernethy has collaborated with scholars based in United Kingdom, Malawi and Netherlands. Frequent co-authors include Alan P. Johnson, Elizabeth Sheridan, Rebecca Guy, Russell Hope, John Davies, G. Duckworth, A. Pearson, N A Hinton, Fiona M Ewings and Veronica Mulenga. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Epidemiology and Infection, Clinical Microbiology and Infection, Journal of Medical Microbiology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.